Scarica l'app Stockscreener
37.54
1.62%
0.60
Dopo l'orario di chiusura:
37.60
0.06
+0.16%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$36.94
Aprire:
$36.83
Volume 24 ore:
3.77M
Relative Volume:
1.00
Capitalizzazione di mercato:
$16.23B
Reddito:
$2.31B
Utile/perdita netta:
$1.66B
Rapporto P/E:
16.34
EPS:
2.297
Flusso di cassa netto:
$827.02M
1 W Prestazione:
+0.75%
1M Prestazione:
+6.41%
6M Prestazione:
+14.38%
1 anno Prestazione:
+39.04%
Intervallo 1D:
$36.67
$37.62
Intervallo di 1 settimana:
$35.91
$37.62
Portata 52W:
$24.05
$38.00
Royalty Pharma Plc Stock (RPRX) Company Profile
Nome
Royalty Pharma Plc
Settore
Industria
Telefono
(212) 883-0200
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Confronta RPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
37.54 | 15.97B | 2.31B | 1.66B | 827.02M | 2.297 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Iniziato | Goldman | Buy |
| 2025-05-16 | Iniziato | Morgan Stanley | Overweight |
| 2024-06-03 | Downgrade | UBS | Buy → Neutral |
| 2022-06-14 | Ripresa | UBS | Buy |
| 2022-05-13 | Iniziato | Scotiabank | Sector Outperform |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-30 | Iniziato | Tigress Financial | Buy |
| 2020-11-09 | Aggiornamento | UBS | Neutral → Buy |
| 2020-07-14 | Iniziato | Evercore ISI | In-line |
| 2020-07-13 | Iniziato | BofA Securities | Buy |
| 2020-07-13 | Iniziato | Citigroup | Neutral |
| 2020-07-13 | Iniziato | Cowen | Outperform |
| 2020-07-13 | Iniziato | Goldman | Neutral |
| 2020-07-13 | Iniziato | JP Morgan | Neutral |
| 2020-07-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Iniziato | SunTrust | Buy |
| 2020-07-13 | Iniziato | UBS | Neutral |
Mostra tutto
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Quantitative breakdown of Royalty Pharma plc recent moveMarket Weekly Review & Precise Swing Trade Alerts - newser.com
Historical volatility pattern of Royalty Pharma plc visualizedEarnings Beat & Community Supported Trade Ideas - newser.com
Royalty Pharma PLC $RPRX Shares Purchased by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
Is Royalty Pharma plc stock a top momentum play2025 Volume Leaders & Free Verified High Yield Trade Plans - newser.com
Why Royalty Pharma plc (RPD) stock could outperform next yearMarket Trend Summary & High Conviction Buy Zone Alerts - newser.com
Is Royalty Pharma plc reversing from oversold territoryJuly 2025 Sentiment & Stepwise Trade Execution Plans - newser.com
How Royalty Pharma Prints Cash Without Biotech's Biggest Risks - MSN
Impact Partnership Wealth LLC Purchases 12,329 Shares of Royalty Pharma PLC $RPRX - MarketBeat
What’s the recovery path for long term holders of Royalty Pharma plcTrade Exit Summary & Free Safe Entry Trade Signal Reports - newser.com
Detecting support and resistance levels for Royalty Pharma plcEarnings Trend Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Using Python tools to backtest Royalty Pharma plc strategiesPortfolio Growth Summary & Technical Entry and Exit Alerts - newser.com
Why retail investors pile into Royalty Pharma plc stockQuarterly Trade Report & AI Forecasted Entry and Exit Points - newser.com
Why Royalty Pharma plc (RPD) stock could rally stronglyQuarterly Market Review & Community Consensus Trade Signals - newser.com
Is Royalty Pharma plc stock a safe investment in uncertain marketsGold Moves & Low Drawdown Momentum Trade Ideas - newser.com
Is Royalty Pharma plc (RPD) stock a buy during volatile marketsJuly 2025 Action & High Accuracy Swing Entry Alerts - newser.com
What MACD signals say about Royalty Pharma plc2025 Analyst Calls & Free Community Supported Trade Ideas - newser.com
Whalen Wealth Management Inc. Makes New Investment in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma Plc Experiences Evaluation Revision Amidst Mixed Market Indicators - Markets Mojo
Royalty Pharma (RPRX) to Release Quarterly Earnings on Wednesday - MarketBeat
What the charts say about Royalty Pharma plc todayTrade Risk Report & Capital Efficiency Focused Ideas - newser.com
Royalty Pharma (RPRX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Royalty Pharma PLC (NASDAQ:RPRX) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Will Royalty Pharma plc (RPD) stock hit Wall Street targetsBond Market & Low Drawdown Trading Strategies - newser.com
Sumitomo Mitsui Trust Group Inc. Purchases 29,996 Shares of Royalty Pharma PLC $RPRX - MarketBeat
2 Reasons to Avoid RPRX and 1 Stock to Buy Instead - Yahoo Finance
Investors in Royalty Pharma (NASDAQ:RPRX) Have Seen Notable Returns of 41% Over the Past Year - 富途牛牛
What Do Analysts Think About Royalty Pharma Plc (RPRX)? - MSN
Can Royalty Pharma plc stock beat analyst upgrades2025 Price Action Summary & Verified Swing Trading Watchlists - Fundação Cultural do Pará
Royalty Pharma Plc Azioni (RPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):